Full Committee Hearing - Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak
Date:
Thursday, November 15 2012, 9:45 AM
Place:
106 Dirksen Senate Office Building
Witnessesreturn to top
Panel I
-
Dr. Beth Bell , Director, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
-
Dr. Peggy Hamburg , Commissioner, Food and Drug Administration, Washington, DC
-
Dr. Lauren Smith , Interim Commissioner, Department of Public Health, Boston, MA
Panel II
-
Barry Cadden , Owner and Director of Pharmacy, New England Compounding Center, Framingham, MA
Panel III
-
Dr. Marion Kainer , Director, Healthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of Health, Nashville, TN
-
David G. Miller , Executive Vice President and CEO, International Academy of Compounding Pharmacy, Missouri City, TX
-
Dr. Kasey K. Thompson , Vice President, Office of Policy, Planning and Communications, American Society of Health-System Pharmacists, Bethesda, MD
Recent News
- Alexander: Block, Griffin Should Leave NLRB While Senate Considers Their Nominations [Ranking Member]
- Alexander-Bennet Bill to Reduce Premature Births Moves Forward in Senate [Ranking Member]
- Harkin Statement on President Obama’s Nominations to the National Labor Relations Board [Chairman]
- Sen. Harkin and Rep. Miller Statement on President Obama’s Minimum Wage Proposal [Chairman]
- Sen. Harkin Statement on HELP Committee Approval of PAHPA, the PREEMIE Act, and New Subcommittee Assignments [Chairman]